OBJECTIVES: To determine the prevalence of 25-hydroxyvitamin D (25[OH]D) deficiency and associations between 25(OH)D deficiency and cardiovascular risk factors in children and adolescents. METHODS: With a nationally representative sample of children aged 1 to 21 years in the National Health and Nutrition Examination Survey 2001-2004 (n = 6275), we measured serum 25(OH)D deficiency and insufficiency (25[OH]D <15 ng/mL and 15-29 ng/mL, respectively) and cardiovascular risk factors. RESULTS: Overall, 9% of the pediatric population, representing 7.6 million US children and adolescents, were 25(OH)D deficient and 61%, representing 50.8 million US children and adolescents, were 25(OH)D insufficient. Only 4% had taken 400 IU of vitamin D per day for the past 30 days. After multivariable adjustment, those who were older (odds ratio [OR]: 1.16 [95% confidence interval (CI): 1.12 to 1.20] per year of age), girls (OR: 1.9 [1.6 to 2.4]), non-Hispanic black (OR: 21.9 [13.4 to 35.7]) or Mexican-American (OR: 3.5 [1.9 to 6.4]) compared with non-Hispanic white, obese (OR: 1.9 [1.5 to 2.5]), and those who drank milk less than once a week (OR: 2.9 [2.1 to 3.9]) or used >4 hours of television, video, or computers per day (OR: 1.6 [1.1 to 2.3]) were more likely to be 25(OH)D deficient. Those who used vitamin D supplementation were less likely (OR: 0.4 [0.2 to 0.8]) to be 25(OH)D deficient. Also, after multivariable adjustment, 25(OH)D deficiency was associated with elevated parathyroid hormone levels (OR: 3.6; [1.8 to 7.1]), higher systolic blood pressure (OR: 2.24 mmHg [0.98 to 3.50 mmHg]), and lower serum calcium (OR: -0.10 mg/dL [-0.15 to -0.04 mg/dL]) and high-density lipoprotein cholesterol (OR: -3.03 mg/dL [-5.02 to -1.04]) levels compared with those with 25(OH)D levels > or =30 ng/mL. CONCLUSIONS: 25(OH)D deficiency is common in the general US pediatric population and is associated with adverse cardiovascular risks.
OBJECTIVES: To determine the prevalence of 25-hydroxyvitamin D (25[OH]D) deficiency and associations between 25(OH)Ddeficiency and cardiovascular risk factors in children and adolescents. METHODS: With a nationally representative sample of children aged 1 to 21 years in the National Health and Nutrition Examination Survey 2001-2004 (n = 6275), we measured serum 25(OH)Ddeficiency and insufficiency (25[OH]D <15 ng/mL and 15-29 ng/mL, respectively) and cardiovascular risk factors. RESULTS: Overall, 9% of the pediatric population, representing 7.6 million US children and adolescents, were 25(OH)D deficient and 61%, representing 50.8 million US children and adolescents, were 25(OH)Dinsufficient. Only 4% had taken 400 IU of vitamin D per day for the past 30 days. After multivariable adjustment, those who were older (odds ratio [OR]: 1.16 [95% confidence interval (CI): 1.12 to 1.20] per year of age), girls (OR: 1.9 [1.6 to 2.4]), non-Hispanic black (OR: 21.9 [13.4 to 35.7]) or Mexican-American (OR: 3.5 [1.9 to 6.4]) compared with non-Hispanic white, obese (OR: 1.9 [1.5 to 2.5]), and those who drank milk less than once a week (OR: 2.9 [2.1 to 3.9]) or used >4 hours of television, video, or computers per day (OR: 1.6 [1.1 to 2.3]) were more likely to be 25(OH)D deficient. Those who used vitamin D supplementation were less likely (OR: 0.4 [0.2 to 0.8]) to be 25(OH)D deficient. Also, after multivariable adjustment, 25(OH)D deficiency was associated with elevated parathyroid hormone levels (OR: 3.6; [1.8 to 7.1]), higher systolic blood pressure (OR: 2.24 mmHg [0.98 to 3.50 mmHg]), and lower serum calcium (OR: -0.10 mg/dL [-0.15 to -0.04 mg/dL]) and high-density lipoprotein cholesterol (OR: -3.03 mg/dL [-5.02 to -1.04]) levels compared with those with 25(OH)D levels > or =30 ng/mL. CONCLUSIONS: 25(OH)D deficiency is common in the general US pediatric population and is associated with adverse cardiovascular risks.
Authors: Francis L Weng; Justine Shults; Mary B Leonard; Virginia A Stallings; Babette S Zemel Journal: Am J Clin Nutr Date: 2007-07 Impact factor: 7.045
Authors: H Glerup; K Mikkelsen; L Poulsen; E Hass; S Overbeck; J Thomsen; P Charles; E F Eriksen Journal: J Intern Med Date: 2000-02 Impact factor: 8.989
Authors: Catherine M Gordon; Henry A Feldman; Linda Sinclair; Avery LeBoff Williams; Paul K Kleinman; Jeannette Perez-Rossello; Joanne E Cox Journal: Arch Pediatr Adolesc Med Date: 2008-06
Authors: Laura D Carbone; E William Rosenberg; Elizabeth A Tolley; Michael F Holick; Thomas A Hughes; Mitchell A Watsky; Karen D Barrow; Tai C Chen; Nathaniel K Wilkin; Syamal K Bhattacharya; John C Dowdy; Robert M Sayre; Karl T Weber Journal: Metabolism Date: 2008-06 Impact factor: 8.694
Authors: Kumaravel Rajakumar; John D Fernstrom; Michael F Holick; Janine E Janosky; Susan L Greenspan Journal: Obesity (Silver Spring) Date: 2008-01 Impact factor: 5.002
Authors: Diane Gilbert-Diamond; Ana Baylin; Mercedes Mora-Plazas; Constanza Marin; Joanne E Arsenault; Michael D Hughes; Walter C Willett; Eduardo Villamor Journal: Am J Clin Nutr Date: 2010-10-06 Impact factor: 7.045
Authors: Karen W Phinney; Mary Bedner; Susan S-C Tai; Veronica V Vamathevan; Lane C Sander; Katherine E Sharpless; Stephen A Wise; James H Yen; Rosemary L Schleicher; Madhulika Chaudhary-Webb; Christine M Pfeiffer; Joseph M Betz; Paul M Coates; Mary Frances Picciano Journal: Anal Chem Date: 2011-12-28 Impact factor: 6.986
Authors: Micah L Olson; Naim M Maalouf; Jon D Oden; Perrin C White; Michele R Hutchison Journal: J Clin Endocrinol Metab Date: 2011-11-09 Impact factor: 5.958
Authors: Candace Y Parker-Autry; Alayne D Markland; Alicia C Ballard; Deidra Downs-Gunn; Holly E Richter Journal: Int Urogynecol J Date: 2012-03-08 Impact factor: 2.894
Authors: Amy L Skversky; Juhi Kumar; Matthew K Abramowitz; Frederick J Kaskel; Michal L Melamed Journal: J Clin Endocrinol Metab Date: 2011-09-28 Impact factor: 5.958